Large language models used in clinical decision-making may offer different treatment recommendations depending on how a patient writes their message—even when the medical facts remain unchanged.
The FDA has approved dupilumab as the first targeted treatment for adults with bullous pemphigoid, showing improved remission rates and reduced corticosteroid use.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
A decade-long analysis tracked global trends, key authors, drug developments, and growing research volume in studies focused on atopic dermatitis-related itch.
Researchers uncovered how herpes simplex virus type 1 reprograms human chromatin structure by hijacking transcriptional machinery, potentially revealing a new antiviral target.